drugset / Trial / NCT01285245
Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test whether anakinra is able to reduce insulin resistance. This will be tested in overweighted type I diabetes mellitus patients, which have no residual beta-cell function. By using this patient group, all positive effects on glycemic control should be the consequence of improved insulin sensitivity.
Timeline
- Start
- 2011-04
- Primary completion
- 2011-09
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anakinra | Protein / enzyme biologic | 100 mg | Subcutaneous |